Prevalence and predictors of potential drug-drug interactions in the elderly: A cross-sectional study in the Brazilian primary public health system

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 15, Issue 2, 2012, Pages 344-354

  Neto, Paulo Roque Obreli ^a   Nobili, Alessandro ^b   Marusic, Srecko ^c   Pilger, Diogo ^d   Guidoni, Camilo Molino ^e   Baldoni, André de Oliveira ^e   Cruciol Souza, Joice Mara ^f   da Cruz, Alessandra Negri ^g   Gaeti, Walderez Penteado ^a   Cuman, Roberto Kenji Nakamura ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c University of Zagreb School of Medicine   (Croatia)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f STATE UNIVERSITY OF LONDRINA   (Brazil)

^g Faculdades Integradas de Ourinhos (FIO)   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMITRIPTYLINE; ANALGESIC AGENT; ANILIDE; ANTITHROMBOCYTIC AGENT; BETA LACTAM ANTIBIOTIC; BEZAFIBRATE; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CYTOCHROME P450; DIAZEPAM; DIGITALIS; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUOXETINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; LOSARTAN; OMEPRAZOLE; PENICILLIN G; SIMVASTATIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TICLOPIDINE; UNINDEXED DRUG; WARFARIN;

AGE; AGED; AMITRYPTILINE TOXICITY; ARTICLE; BLEEDING; BRAZIL; CENTRAL NERVOUS SYSTEM DEPRESSION; CITY; COMORBIDITY; CROSS-SECTIONAL STUDY; DIGESTIVE SYSTEM INJURY; DIGITALIS INTOXICATION; DRUG DRUG INTERACTION; DRUG INTERACTION; FOLLOW UP; GENDER; GERIATRIC PATIENT; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPERTENSION; INTOXICATION; LOGISTIC REGRESSION ANALYSIS; MEDICAL RECORD; MYOPATHY; POLYPHARMACY; PREDICTION; PRESCRIPTION; PREVALENCE; PRIMARY HEALTH CARE; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; RESPIRATION DEPRESSION; RHABDOMYOLYSIS; SAMPLE; SIDE EFFECT;

EID: 84860857088     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j37k5w     Document Type: Article

References (39)

1. Obreli-Neto PR, Vieira JC, Teixeira DRA, Silva FP, Gaetti WP, Cuman RKN. Potential risks in drug prescriptions to elderly: a cross-sectional study in the public primary health care system of Ourinhos micro-region, Brazil. Acta Farm Bonaerense, 2011; 30: 629-635.
2. Doubova-Dubova SV, Reyes-Morales H, Torres-Arreola L del P, Suárez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res, 2007; 7: 147.
3. Palloni A, Pinto-Aguirre G, Pelaez M. Demographic and health conditions of ageing in Latin America and the Caribbean. Int J Epidemiol, 2002; 31: 762-771.
4. Hamilton RA, Briceland LL, Andritz MH. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population. Pharmacotherapy, 1998; 18: 1112-1120.
5. Shad MU, Marsh C, Preskorn SH. The economic consequences of a drug-drug interaction. J Clin Psychopharmacol, 2001; 21: 119-120.
6. Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc, 1998; 36: 1092-1098.
7. Janchawee B, Wongpoowarak W, Owatranporn T, Chongsuvivatwong V. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther, 2005; 30: 13-20.
8. Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci, 2006; 9: 427-433.
9. Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther, 2008; 33: 141-151.
10. United Nations Programme on Ageing. The Ageing of the World's Population. In: http://www.un.org/ageing/popageing.html.
11. Agência Nacional de Vigilância Sanitária do Brasil. Law no5991, of December 17, 1973. In: http://www.anvisa.gov.br/legis/consolidada/lei_5991_73.htm.
12. WHO Collaborating Centre for Drug Statistics Methodology. ACT/DDD Index. In: http://www.whocc.no/atcddd/.
13. Tobi H, Faber A, van den Berg PB, Drane JW, de Jong-van den Berg LT. Studying co-medication patterns: the impact of definitions. Pharmacoepidemiol Drug Saf, 2006; 16: 405-411.
14. DrugDigest. Check interactions. www.drugdigest.org/wps/portal/ddigest.
15. Drugs. Drug interaction checker. www.drugd.com/drug_interactions.html.
16. Medscape. Drug information. http://www.medscape.com/druginfo/druginterchecker.
17. Micromedex. Micromedex healthcare series. http://www.periodicos.capes.gov.br/.
18. Vonbach P, Dubied A, Krähenbühl S, Beer JH. Evaluation of frequently used drug interaction screening programs. Pharm World Sci, 2008; 30: 367-374.
19. Lacy, C.F.; Armstrong, L.L.; Goldman, P.M.; Lance, L.L, Lexi-Comp's Drug Information Handbook with International Trade Names Index 2010-2011. Lexi-Comp, Hudson, OH, USA, 2010.
20. Nobili A, Pasina L, Tettamanti M, Lucca U, Riva E, Marzona I, Monesi L, Cucchiani R, Bortolotti A, Fortino I, Merlino L, Walter Locatelli G, Giuliani G. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther, 2009; 34: 377-386.
21. Costa AJ. Potential drug interactions in an ambulatory geriatric population. Fam Pract, 1991; 8: 234-236.
22. Köhler GI, Bode-Böger SM, Busse R, Hoopmann M, Welte T, Böger RH. Drug-drug interactions in medical patients: effects of inhospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther, 2000; 38: 504-513.
23. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol, 2004; 57: 6-14.
24. Lin CF, Wang CY, Bai CH. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study. Drugs Aging, 2011; 28: 219-225.
25. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care, 2003; 21: 153-158.
26. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly. A survey of over 600 000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf, 2007; 30: 911-918.
27. Cook RI, Render M, Woods DD. Gaps in the continuity of care and progress on patient safety. BMJ, 2000; 320: 791-794.
28. Cabrera MAS, Dip RM, Furlan MO, Rodrigues SL. Use of drugs that act on the cytochrome P450 system in the elderly. Clinics (Sao Paulo), 2009; 64: 273-278.
29. Tanaka E. Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease. J Clin Pharm Ther, 1998; 23: 161-170.
30. Cheng PY, Morgan ET. Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab, 2001; 2: 165-183.
31. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean R, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med, 2003; 163: 2716-2723.
32. Ryan C, O'Mahony D, Kennedy J, Weedle P, Barry P, Gallagher P, Byrne S. Appropriate prescribing in the elderly: an investigation of two screening tools, Beers criteria considering diagnosis and independent of diagnosis and improved prescribing in the elderly tool to identify inappropriate use of medicines in the elderly in primary care in Ireland. J Clin Pharm Ther, 2009; 34: 369-376.
33. Lai HY, Hwang SJ, Chen YC, Chen TJ, Lin MH, Chen LK. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Clin Ther, 2009; 31: 1859-1870.
34. Janchawee B, Owatranporn T, Mahatthanatrakul W, Chongsuvivatwong V. Clinical drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther, 2005; 30: 583-590.
35. Caccia S, Garattini S, Pasina L, Nobili A. Predicting the clinical relevance of drug interactions from pre-approval studies. Drug Saf, 2009; 32: 1017-1039.
36. Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, Lipton RB. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc, 2003; 44: 136-141.
37. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet, 2007; 370: 185-191.
38. Guidoni CM, Baldoni AO, Obreli-Neto PR, Pereira LRL. Fontes de informações sobre interações medicamentosas: Há concordância entre elas? Rev Univ Vale Rio Verde, 2011; 9: 84-91.
39. Indermitte J, Reber D, Beutler M, Bruppacher R, Hersberger KE. Prevalence and patient awareness of selected potential drug interactions with self-medication. J Clin Pharm Ther, 2007; 32: 149-159.